Rhythm and connection: music therapy shows promise for dementia patients and caregivers
NCT ID NCT06768996
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study explores whether a simple music activity—tapping along to rhythms together—can improve social attention and feelings of closeness in people with frontotemporal dementia or Alzheimer's disease, and their caregivers. Eighty patient-caregiver pairs will participate in a controlled experiment. The goal is to see if shared rhythm-making boosts social skills and relationship quality, and to understand which brain networks might be involved.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Synchronous rhythm production (a musical activity where participants tap along to rhythms)
- What this could lead to
- If it works, this could point toward a simple, enjoyable way to improve social connection and attention for people with dementia and their caregivers.
- What could go wrong
- This is a small, early exploratory study with only 80 participants, so results may not apply to everyone. The benefits may be modest or not last long.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
80 people
The number who actually took part.
- Started
-
Jan 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
55 to 89 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion (patients) * Male or female ≥ 55 years of age living with bvFTD; or ≥ 70 years of age living with AD. * Documentation of a bvFTD or AD diagnosis as evidenced by one or more known clinical features. * Written informed consent obtained from subject. Inclusion (caregivers) * Male or female ≥ 55 years of age living without diagnosis of neurological or psychiatric disease. * Individual capable of independent execution of activities of daily living, including personal care and hygiene, dressing, eating, use of a toilet, and mobility. * Written informed consent. Exclusion (patients) * Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data. * community-dwelling individuals not living with bvFTD * community-dwelling individuals with normal cognitive functioning * Individuals living with Alzheimer's disease or related dementias (primary progressive aphasia, semantic variant FTD, Lewy body dementia, vascular dementia, Parkinson's disease, or mixed dementia) * Individuals with a score of 2 or higher on the CDR * Individuals with a history of neuropsychiatric illness that would interfere with performance (e.g., transient psych hx of depression okay, hx of schizophrenia will be excluded) or medicated depression to control symptoms. * Individuals with unstable (e.g., cancer other than basal cell skin) or chronic (e.g., severe diabetes) medical conditions * Individuals with MRI contraindications (e.g., pregnancy, claustrophobia, metal implants that are contraindicated for MRI) * Individuals with physical impairment(s) precluding motor response * Individuals with inability to walk two blocks without stopping * Individuals with hearing or vision deficits that will not allow for completion of testing; inability to hear conversation conducted at an average volume (\~60 dB) * Individuals who practice music making or production for at least 30-mins per week * This may include instrumental or vocal, writing or arranging, alone or in groups * Listening to music for more than 30-mins weekly will not exclude the individual from the study Exclusion (Caregivers) * Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data. * Community-dwelling individuals living with diagnosis of a neurological or psychiatric disease o Community-dwelling individuals with abnormal cognitive functioning * Individuals living with dementia * Individuals with a history of neuropsychiatric illness that would interfere with performance (e.g., transient psych hx of depression okay, hx of schizophrenia will be excluded) or medicated depression to control symptoms * Individuals with unstable (e.g., cancer other than basal cell carcinoma) or chronic (e.g., severe diabetes) medical conditions * Individuals with physical impairment(s) precluding motor control * Individuals with inability to walk two blocks without stopping * Individuals with hearing or vision deficits that will not allow for completion of testing; inability to hear conversation conducted at an average volume (\~60 dB) * Individuals who practice music making or production for at least 30-mins per week * This may include instrumental or vocal, writing or arranging, alone or in groups * Listening to music for more than 30-mins weekly will not exclude the individual from the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alzheimer disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sandler Neurosciences Center
San Francisco, California, 94158, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Can a massive data registry crack the code of Parkinson's and related brain diseases?
- Can a gentle electric current calm the mind in Alzheimer's?
- Alzheimer's vaccine aims to clear amyloid before memory fades
- Blood, eye, and brain scans team up to spot Alzheimer's earlier
- Can a home device slow Alzheimer's? pilot study tests pulsed electromagnetic therapy